Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06296589 · ClinicalTrials.gov registry record · NA
Trauma-Informed Guilt Reduction Therapy Compared to Prolonged Exposure
A NA study of Stress Disorders, Post-Traumatic, sponsored by Veterans Medical Research Foundation.
- Recruiting
- Registry status
- NA
- Development phase
- 158
- Enrollment target
- 3
- Study locations
NCT06296589: Recruiting NA study of Stress Disorders, Post-Traumatic, sponsored by Veterans Medical Research Foundation.
NCT06296589 is a NA study of Stress Disorders, Post-Traumatic that is actively recruiting participants, run by Veterans Medical Research Foundation. The registered enrollment target is 158 participants, roughly in line with the 154-participant average among 66 other Stress Disorders, Post-Traumatic trials with a reported enrollment target. The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06296589, a NA study of Stress Disorders, Post-Traumatic, is actively recruiting participants, sponsored by Veterans Medical Research Foundation.
- RECRUITING
- Registry status
- NA
- Development phase
- 158 participants
- Enrollment target
- 3
- Study locations
Study Summary
The goal of this clinical trial is to learn if receiving Trauma-Informed Guilt Reduction (TrIGR) Therapy is as effective as receiving Prolonged Exposure Therapy among veterans with PTSD and trauma related guilt. The main questions it aims to answer are: Will TrIGR be comparable to PE in terms of PTSD symptom reduction? Will it TrIGR be comparable to PE in improving functioning and reducing depression symptoms? Will it be superior in improving trauma-related guilt and shame?
Primary Outcome
Measures PTSD symptom severity, score range 0-80, higher scores mean greater symptom severity
Conditions Studied
Interventions
- BEHAVIORAL Prolonged Exposure Therapy
- BEHAVIORAL Trauma Informed Guilt Reduction Therapy
Study Locations (3)
Arkansas
- Little Rock Veterans Health Care System (LRVHCS) - Little Rock
Louisiana
- Southeast Louisiana Veterans Health Care System (SLVHCS) - New Orleans
Wisconsin
- William S. Middleton Memorial Hospital - Madison
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 158 participants |
| Start Date | 2024-12-01 |
| Est. Completion | 2027-08 |
| Phase | NA |
What NCT06296589 shows while recruiting
NCT06296589 is an interventional study that assigns participants to a tested intervention. The registered 158 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 154-participant average among 66 other Stress Disorders, Post-Traumatic trials with a reported enrollment target.
The record links to 1 condition, with Stress Disorders, Post-Traumatic appearing as the primary indexed condition, and to 2 interventions - of which Prolonged Exposure Therapy is the first listed.
NCT06296589 reports a single indexed study location in Arkansas, Louisiana, Wisconsin.
Frequently Asked Questions
What is clinical trial NCT06296589 about?
NCT06296589 is a clinical study titled "Trauma-Informed Guilt Reduction Therapy Compared to Prolonged Exposure". The goal of this clinical trial is to learn if receiving Trauma-Informed Guilt Reduction (TrIGR) Therapy is as effective as receiving Prolonged Exposure Therapy among veterans with PTSD and trauma related guilt. The main questions it aims to answer are: Will TrIGR be comparable to PE in terms of PT...
What is the current status of trial NCT06296589?
This trial is currently recruiting. It is a NA study. The enrollment target is 158 participants. The study started on 2024-12-01. Estimated completion is 2027-08.
What conditions does trial NCT06296589 study?
This clinical trial studies the following conditions: Stress Disorders, Post-Traumatic.
What interventions are being tested in trial NCT06296589?
The interventions under investigation include: Prolonged Exposure Therapy (BEHAVIORAL), Trauma Informed Guilt Reduction Therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT06296589?
This trial is sponsored by Veterans Medical Research Foundation, which has 35 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06296589 being conducted?
This trial has 3 study locations across Arkansas, Louisiana, Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stress Disorders, Post-Traumatic
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06296589's enrollment target sits among peer trials
158 18th of 66 higher than 49 of 66 other Stress Disorders, Post-Traumatic trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Stress Disorders, Post-Traumatic trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Manage Emotions to Reduce Aggression (MERA)
RECRUITING · NA
-
SMART Therapist Training: A Hybrid Factorial-SMART Design
RECRUITING · NA
-
Postpartum Care in the NICU (PeliCaN) Transitions
RECRUITING · NA
-
Healthy Recovery After Trauma Study
RECRUITING · NA
-
Intervention to Enhance Coping and Help-seeking Among Youth in Foster Care
RECRUITING · NA
-
Whole Health in VA Mental Health: Omnis Salutis
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04486833 · 158 participants · Phase 1
Quaratusugene Ozeplasmid (Reqorsa) and Osimertinib in Patients With Advanced Lung Cancer Who Progressed on Osimertinib
- NCT04697966 · 158 participants · NA
Mechanisms and Predictors of Change in App-Based Mindfulness Training for Adolescents
- NCT04969835 · 158 participants · Phase 1
A Study Evaluating the Safety, Pharmacokinetics and Early Efficacy of AVA6000 in Solid Tumours
- NCT05230732 · 158 participants · NA
Neuromodulation of Inflammation and Endothelial Function
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI